MASTROIANNI, CHIARA
 Distribuzione geografica
Continente #
NA - Nord America 2.001
AS - Asia 751
EU - Europa 433
SA - Sud America 130
Continente sconosciuto - Info sul continente non disponibili 78
AF - Africa 15
OC - Oceania 2
Totale 3.410
Nazione #
US - Stati Uniti d'America 1.950
SG - Singapore 330
CN - Cina 117
IT - Italia 110
BR - Brasile 105
RU - Federazione Russa 99
BD - Bangladesh 81
HK - Hong Kong 73
VN - Vietnam 70
DE - Germania 53
IE - Irlanda 32
GB - Regno Unito 30
JP - Giappone 29
CA - Canada 17
FR - Francia 17
MX - Messico 17
SE - Svezia 17
FI - Finlandia 14
IN - India 13
NL - Olanda 12
AT - Austria 10
AR - Argentina 8
CZ - Repubblica Ceca 8
PL - Polonia 8
LT - Lituania 7
TR - Turchia 7
ZA - Sudafrica 7
EC - Ecuador 6
JM - Giamaica 5
UA - Ucraina 5
AE - Emirati Arabi Uniti 4
ES - Italia 4
ID - Indonesia 4
CO - Colombia 3
CR - Costa Rica 3
HN - Honduras 3
JO - Giordania 3
MA - Marocco 3
VE - Venezuela 3
AU - Australia 2
BB - Barbados 2
BE - Belgio 2
EG - Egitto 2
IL - Israele 2
IQ - Iraq 2
IR - Iran 2
KR - Corea 2
PH - Filippine 2
PK - Pakistan 2
PR - Porto Rico 2
PY - Paraguay 2
TT - Trinidad e Tobago 2
UZ - Uzbekistan 2
AL - Albania 1
AM - Armenia 1
AO - Angola 1
BO - Bolivia 1
CL - Cile 1
CW - ???statistics.table.value.countryCode.CW??? 1
ET - Etiopia 1
EU - Europa 1
GF - Guiana Francese 1
HR - Croazia 1
KE - Kenya 1
KG - Kirghizistan 1
MD - Moldavia 1
NO - Norvegia 1
NP - Nepal 1
PS - Palestinian Territory 1
RO - Romania 1
SA - Arabia Saudita 1
TW - Taiwan 1
Totale 3.334
Città #
Wilmington 440
Houston 280
Singapore 209
San Jose 114
Ashburn 97
Woodbridge 81
Hong Kong 72
Chandler 59
Fairfield 58
Beijing 50
New York 41
Council Bluffs 39
Los Angeles 37
Santa Clara 34
Rome 32
Ho Chi Minh City 29
Tokyo 29
Seattle 23
The Dalles 23
Cambridge 21
Dublin 20
Denver 19
Buffalo 18
Hanoi 18
Munich 18
Ann Arbor 17
Dallas 15
Moscow 15
Nuremberg 15
São Paulo 14
Dearborn 11
Helsinki 11
Medford 11
Boardman 10
Orem 10
Atlanta 9
Amsterdam 8
Brooklyn 8
Montreal 8
Johannesburg 7
London 7
Warsaw 7
Brno 6
Mexico City 6
Naples 6
Palermo 6
Phoenix 6
Vienna 6
Da Nang 5
Lauterbourg 5
Lawrence 5
Manchester 5
Milan 5
Redondo Beach 5
Stockholm 5
Suzhou 5
Chennai 4
Engelhard 4
Florence 4
Frankfurt am Main 4
Jacksonville 4
Kingston 4
Palo Alto 4
San Francisco 4
Turin 4
Amman 3
Boston 3
Catania 3
Chicago 3
Colorado Springs 3
Guangzhou 3
Guayaquil 3
Miami 3
Mumbai 3
Nanjing 3
North Bergen 3
Querétaro 3
Ribeirão Preto 3
Salvador 3
San Diego 3
Anápolis 2
Austin 2
Belo Horizonte 2
Bologna 2
Boydton 2
Bridgetown 2
Brussels 2
Campo Bom 2
Columbus 2
Concord 2
Dhaka 2
Dubai 2
Elk Grove Village 2
Fortaleza 2
Gonzales 2
Hounslow 2
Hải Dương 2
Itapemirim 2
Jackson 2
Jakarta 2
Totale 2.241
Nome #
Dynamics and phylogenetic relationships of HIV-1 transmitted drug resistance according to subtype in Italy over the years 2000-14 387
HDV can constrain HBV genetic evolution in hbsag: Implications for the identification of innovative pharmacological targets 351
Trend of estimated glomerular filtration rate during ombistasvir/paritaprevir/ritonavir plus dasabuvir± ribavirin in HIV/HCV co-infected patients 323
Impact of new DAA therapy on real clinical practice: A multicenter region-wide cohort study 320
A snapshot of virological presentation and outcome of immunosuppression-driven HBV reactivation from real clinical practice: Evidence of a relevant risk of death and evolution from silent to chronic infection 272
Long-term outcomes of bictegravir/emtricitabine/tenofovir alafenamide as first-line therapy and as switch strategy in virologically suppressed persons with HIV: data from the ICONA cohort 139
Active HCV Replication but Not HCV or CMV Seropositive Status Is Associated with Incident and Prevalent Type 2 Diabetes in Persons Living with HIV 115
Genetic signatures specifically clustered in immune active HBsAg regions correlate with immunosuppression-driven HBV reactivation: An extensive analysis of HBV genome. 113
Brief Report: Drop in CD4+ Counts Below 200 Cells/μL After Reaching (or Starting From) Values Higher than 350 Cells/μL in HIV-Infected Patients With Virological Suppression 111
Discontinuation of initial antiretroviral therapy in clinical practice : Moving toward individualized therapy 110
Response to first-line ritonavir-boosted protease inhibitors (PI/r)-based regimens in HIV positive patients presenting to care with low CD4 counts: Data from the Icona Foundation Cohort 105
HDV epidemic in Central Italy is stable over the last two decades and is characterized by the circulation of multiple HDV subgenotypes 1 inducing different inflammatory stimuli 103
Advances in Transcatheter Aortic Valve Therapy in Bicuspid Aortic Valve Disease: Insight into Patient Selection, Management, and Future Directions 100
Efficacy and tolerability of switching to a dual therapy with darunavir/ritonavir plus raltegravir in HIV-infected patients with HIV-1 RNA <50~cp/mL 99
Stable temporal trend of HDV seroprevalence in central Italy across the last two decades with the circulation of HDV sub-genotypes 1 inducing different inflammatory stimuli 98
Incidence and progression to cirrhosis of new hepatitis C virus infections in persons living with human immunodeficiency virus 92
Factors influencing place of death and disenrollment among patients receiving specialist palliative care 92
Evolution of major non-HIV-related comorbidities in HIV-infected patients in the Italian Cohort of Individuals, Na{\"i}ve for Antiretrovirals (ICONA) Foundation Study cohort in the period 2004?2014 91
The Wounded Healer: A Phenomenological Study on Hospital Nurses Who Contracted COVID-19 90
HDV INFECTION IS STABLE IN CENTRAL ITALY ACROSS THE LAST TWO DECADES AND IS CHARACTERIZED BY THE CIRCULATION OF MULTIPLE HDV SUB-GENOTYPES 1 WITH A DIFFERENT PRO-INFLAMMATORY POTENTIAL 90
Is physician assessment of alcohol consumption useful in predicting risk of severe liver disease among people with HIV and HIV/HCV co-infection? 90
First-line antiretroviral therapy with efavirenz plus tenofovir disiproxil fumarate/emtricitabine or rilpivirine plus tenofovir disiproxil fumarate/emtricitabine: a durability comparison 77
Long-acting injectable antiretrovirals for HIV treatment in the ICONA cohort: physicians’ and nurses’ points of view 42
Totale 3.410
Categoria #
all - tutte 12.045
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.045


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202260 0 0 0 3 7 3 7 4 12 5 5 14
2022/2023129 5 10 16 10 17 23 12 15 7 7 4 3
2023/2024145 16 5 3 1 9 19 0 4 6 59 1 22
2024/2025623 17 128 63 36 20 71 77 20 58 40 44 49
2025/20261.089 88 54 97 124 132 47 120 117 108 78 58 66
2026/2027351 67 65 153 66 0 0 0 0 0 0 0 0
Totale 3.410